These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


373 related items for PubMed ID: 10562364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L.
    Cancer; 1998 Jan 01; 82(1):49-59. PubMed ID: 9428479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG, Toth M, Flynn S, Fischer D, Carter D.
    J Clin Oncol; 1992 Dec 01; 10(12):1839-47. PubMed ID: 1453198
    [Abstract] [Full Text] [Related]

  • 7. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
    Sampedro A, Salas-Bustamante A, López-Artimez M, García-Muñíz JL, Urdiales G.
    Anal Quant Cytol Histol; 1999 Aug 01; 21(4):347-52. PubMed ID: 10560513
    [Abstract] [Full Text] [Related]

  • 8. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE, André S, Soares J.
    J Clin Pathol; 1999 Aug 01; 52(8):604-11. PubMed ID: 10645231
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
    Ohyama S, Yonemura Y, Miyazaki I.
    Cancer; 1990 Jan 01; 65(1):116-21. PubMed ID: 2293858
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E, Abdalla F, Buhmeida A, Alshrad M, Salem N, Pyrhönen S, Collan Y.
    Oncology; 2012 Jan 01; 83(3):165-76. PubMed ID: 22906963
    [Abstract] [Full Text] [Related]

  • 11. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S, Lee AK, Tahan SR, Figoni MA, Wiley BD, Heatley GJ, Silverman ML.
    Cancer; 1992 Oct 01; 70(7):1943-50. PubMed ID: 1525770
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P.
    Cancer; 1997 Jun 01; 79(11):2073-86. PubMed ID: 9179053
    [Abstract] [Full Text] [Related]

  • 13. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Cancer Radiother; 2005 Dec 01; 9(8):575-86. PubMed ID: 16243560
    [Abstract] [Full Text] [Related]

  • 14. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Breast Cancer Res Treat; 2005 May 01; 91(1):61-71. PubMed ID: 15868432
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of ploidy and S-phase fraction in primary intraoral squamous cell carcinoma and their corresponding metastatic lymph nodes.
    El-Deftar MF, El Gerzawi SM, Abdel-Azim AA, Tohamy SM.
    J Egypt Natl Canc Inst; 2012 Mar 01; 24(1):7-14. PubMed ID: 23587227
    [Abstract] [Full Text] [Related]

  • 16. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
    Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S.
    Oncology; 1996 Mar 01; 53(3):182-91. PubMed ID: 8643219
    [Abstract] [Full Text] [Related]

  • 17. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A.
    J Cancer Res Clin Oncol; 2002 Dec 01; 128(12):650-8. PubMed ID: 12474051
    [Abstract] [Full Text] [Related]

  • 18. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS, Gersell DJ, Yim S.
    Gynecol Oncol; 2001 Jun 01; 81(3):466-76. PubMed ID: 11371140
    [Abstract] [Full Text] [Related]

  • 19. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R, Guerrieri C, Stâl O, Malmström H, Simonsen E.
    Gynecol Oncol; 1998 Jan 01; 68(1):54-61. PubMed ID: 9454661
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A.
    Gynecol Oncol; 1995 Aug 01; 58(2):149-56. PubMed ID: 7622098
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.